You are here

Novartis

In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'

Endpoints

Thu, 01/26/23 - 05:05 pm

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE

Fierce Pharma

Thu, 01/26/23 - 10:40 am

Gilead Sciences

Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio

Endpoints

Wed, 01/25/23 - 10:44 am

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Endpoints

Tue, 01/24/23 - 06:18 pm

multiple sclerosis

Novartis CEO says Covid likely to become endemic, urges investment in pandemic preparedness

CNBC

Fri, 01/20/23 - 10:32 am

A year of two halves for US approvals

EP Vantage

Thu, 01/19/23 - 09:38 am

Bristol Myers Squibb

AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out

Fierce Pharma

Wed, 01/18/23 - 10:53 pm

EMA weighs new safety guidance for Novartis’ gene therapy Zolgensma

BioPharma Dive

Tue, 01/17/23 - 10:26 am

JPM23: After rock climbing in biotech, Novartis' CMO is back to support hopeful hike to US summit

Fierce Biotech

Thu, 01/12/23 - 10:36 am

Dicerna Pharmaceuticals

JPM Day 1: Highlights

BioSpace

Mon, 01/9/23 - 11:01 pm

Sarepta Therapeutics

Arrowhead Pharmaceuticals

Bristol Myers Squibb

JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says

Fierce Pharma

Mon, 01/9/23 - 10:43 pm

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Thu, 01/5/23 - 09:57 am

The biggest-selling pharma companies of 2023

EP Vantage

Wed, 01/4/23 - 05:20 pm

Novartis to cut 280+ jobs in New Jersey

Endpoints

Mon, 12/19/22 - 10:21 pm

AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in

Fierce Biotech

Fri, 12/16/22 - 10:47 am

Novartis sells U.S. rights to five drugs to Harrow for up to $175M

Medical Marketing and Media

Wed, 12/14/22 - 07:43 pm

ASH: Novartis stays the course with cell therapy bet as competitors line up 'off-the-shelf' options

Fierce Biotech

Tue, 12/13/22 - 10:36 am

ASH: Novartis says rare disease med 'stands on its own,' diving deeper into head-to-head win against AstraZeneca

Fierce Biotech

Tue, 12/13/22 - 10:28 am

Clovis files for bankruptcy, will keep operating and plans to sell pipeline asset to Novartis

Endpoints

Mon, 12/12/22 - 10:14 am

Clovis Oncology

Novartis' iptacopan meets PhIII test in fight against rare blood disease

Endpoints

Thu, 12/8/22 - 10:37 am

clinical trials

paroxysmal nocturnal hemoglobinuria

Pages